Updated
–
The MHRA is the first regulator in the world to approve the Valneva vaccine
–
The vaccine against Covid-19 of the Franco-Austrian laboratory Valneva has been approved in the UK, the regulatory agency MHRA has announced.
“The vaccine Covid-19 developed by Valneva has received regulatory approval from the Medicines and Healthcare Products Regulatory Agency” (MHRA), the agency said in a statement.
The MHRA is the first regulator in the world to approve the Valneva.
Valneva had already received authorization for the emergency use of his inoculant on the part of Barin, who acquired a million doses.
The laboratory also signed an agreement with the European Commission to provide a maximum of 60 million doses in 2022 and 2023.
Valneva It is the sixth vaccine against the new coronavirus to receive authorization in the United Kingdom, along with those of AstraZeneca, Pfizer, Moderna, Janssen (Johnson & Johnson) y Novavax.
“The Independent Commission for Medicinal Products for Human Use and its group of experts on Covid-19 have carefully examined the available evidence and (…) the benefit/risk ratio is positive,” Professor Munir Pirmohamed, chairman of the commission, was quoted as saying in a statement.
The vaccine Valneva It can be used among people from 18 to 50 years old and requires an interval of 28 days between the first and second dose.
The vaccine can be stored at a temperature of refrigeracin normalwhich makes it easier to use.
The UK has been hit hard by the coronavirus pandemic, which has caused more than 171,000 deaths.
More than 92% of its population aged 12 years or older have received a first dose of a vaccine against covid-19, while 86.2% received the second dose and 67.8% have a booster dose.
According to the criteria of
